von Dr. Bernd Fabry | Dez 31, 2020 | Allgemein
Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug originally developed by Emory University for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral effect...
von Dr. Bernd Fabry | Dez 21, 2020 | Allgemein
The patent dispute between Nokia and Daimler concerning alleged infringement of various mobile communications patents will now step to the ECJ. On Thursday December 17, 2020 the Düsseldorf Regional Court (LG) announced submitting several questions to the ECJ...
von Dr. Bernd Fabry | Dez 6, 2020 | Allgemein
„This is a political train that does not stop.“ Prof. Winfried Tillmann The Unified Patent Court (EPC) is a planned court with two instances for disputes concerning the European unitary patent. The jurisdiction of the court comprises nullity actions against European...
von Dr. Bernd Fabry | Nov 21, 2020 | Allgemein
The Brexit becomes effective At the end of the year, the transitional period expires and the Brexit becomes effective. Recently, the rules for the extension of Union trademarks to the UK have been clarified: 1. All Union trademarks.. registered or to be registered by...
von Dr. Martin Fabry | Nov 21, 2020 | Allgemein
The second Corona wave As the second Corona wave is accelerating in Europe and the US, thereby forcing us again to restrict our social interaction to a bare minimum, the announcements in recent days by Pfizer/BioNTech and Moderna of highly effective vaccines...
von Dr. Martin Fabry | Okt 16, 2020 | Allgemein
Controlling COVID19 infections is essential to prevent further damage to society and the collapse of health care systems. PCR-based methods have been the gold standard testing approach for the first phase of this pandemic. However, low throughput, high costs and long...
